Notice of Half-Year Financial Results
Faron Pharmaceuticals Ltd (“Faron” or the “Company”) Faron Pharmaceuticals to Report Half-Year Financial Results on Thursday, August 25, 2022 Company Announcement, August 8, 2022 at 02:00 AM (EDT) / 07:00 AM (BST) / 09:00 AM (EEST) TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, will report unaudited half-year financial results for the six months ended